SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of SunLink Health Systems, Inc. (NYSE American – SSY)

BALA CYNWYD – January 6, 2025/Globe Newswire/ – Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of SunLink Health Systems, Inc. (“SunLink Health” or the “Company”) (NYSE American – SSY) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Regional Health Properties, Inc. (“Regional”) (NYSE American: RHE) (NYSE American: RHE-PA). As a result of the transaction, SunLink shareholders will own approximately 43.0% of the combined company.

The investigation concerns whether the SunLink Health Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of the Company’s shareholders in the combined company.

If you own shares of SunLink Health stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman by email at clients@brodsky-smith.com, or call toll free 855-576-4847.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.